Mutagenicity of sulfoscanate: a comparative study.

Area of Science:

• Toxicology
• Medicinal Chemistry
• Genetics

Background:

• Sulfoscanate (SSC), nitroscanate (NSC), and amoscanate (ASC) are related compounds with potential biological activities.
• Understanding the mutagenic potential of these compounds is crucial for assessing their safety and efficacy.

Purpose of the Study:

• To compare the mutagenic activity of sulfoscanate (SSC) with nitroscanate (NSC) and amoscanate (ASC).
• To investigate the metabolic pathways involved in the mutagenicity of SSC and NSC.

Main Methods:

• Bacterial reverse mutation assays (Ames test) using Salmonella typhimurium strains TA98 and TA100.
• Testing in strains deficient in O-acetyltransferase (TA98/1,8-DNP(6)) and nitroreductase (TA98NR).
• Analysis of mutagenicity in animal urine after drug administration.

Main Results:

• Sulfoscanate (SSC) demonstrated potent mutagenicity (26.0 and 475.5 revertants/nmole in TA98 and TA100, respectively).
• Nitroscanate (NSC) showed moderate mutagenicity (11.1 and 21.5 revertants/nmole).
• Amoscanate (ASC) was non-mutagenic itself, but its metabolites in urine were mutagenic. Mutagenicity of SSC and NSC was abolished in nitroreductase-deficient strains, and significantly reduced in O-acetyltransferase-deficient strains.

Conclusions:

• The mutagenic activity follows the order: Sulfoscanate (SSC) > Nitroscanate (NSC) > Amoscanate (ASC).
• O-acetyltransferase and nitroreductase enzymes play critical roles in the mutagenic activation of SSC and NSC.
• Further research into the metabolic activation and toxicological profiles of these compounds is warranted.